The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 192 participants.
Also called NCT05386186
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 192 participants
- Registry
-
NCT05386186
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05386186. Randomized; no masking; primary purpose treatment. Start 2022-01-01 (actual); primary completion 2023-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Severe Insulin Deficient Diabetes
- Intervention (Drug)
- Glimepiride
- Intervention (Drug)
- Sitagliptin
- Lead sponsor
- Peking University People's Hospital
- Collaborator
- Peking University First Hospital
- Collaborator
- Jiangsu Province Geriatric Institute
Record details
- Record id
cardio:ct-nct05386186- Content hash
c6ba827bb3ab0470ebb54d1b6c39d2bc2cc1f4deff0555eba3996eb921e99240